皮肤病与性病2024,Vol.46Issue(1) :28-30.DOI:10.3969/j.issn.1002-1310.2024.01.007

鳞状细胞癌抗原在银屑病和特应性皮炎中的表达

Expression of Squamous Cell Carcinoma Antigen in Psoriasis and Atopic Dermatitis

李宜蔓 左卫堂 邓丹琪
皮肤病与性病2024,Vol.46Issue(1) :28-30.DOI:10.3969/j.issn.1002-1310.2024.01.007

鳞状细胞癌抗原在银屑病和特应性皮炎中的表达

Expression of Squamous Cell Carcinoma Antigen in Psoriasis and Atopic Dermatitis

李宜蔓 1左卫堂 2邓丹琪1
扫码查看

作者信息

  • 1. 昆明医科大学第二附属医院皮肤科,云南 昆明 650106
  • 2. 文山壮族苗族自治州人民医院皮肤风湿免疫科,云南文山 663000
  • 折叠

摘要

鳞状细胞癌抗原(squamous cell carcinoma antigen,SCCA)是卵清蛋白丝氨酸蛋白酶抑制剂的家族成员,最初用作鳞状细胞癌的肿瘤标志物.近年来发现SCCA在银屑病、特应性皮炎(atopic dermatitis,AD)等炎症性皮肤病中呈高表达,SCCA作为IL-22/IL-17、IL-4/IL-13的下游分子参与银屑病、特应性皮炎的发生发展.本文将就SCCA与银屑病、特应性皮炎的相关研究进行如下综述.

Abstract

Squamous cell carcinoma antigen(SCCA),a member of the ovalbumin serine protease inhibitor family,was originally used as a tumor marker for squamous cell carcinomas.In recent years,it has been found that SCCA expression is elevated in inflammatory skin diseases such as psoriasis and atopic dermatitis,and SCCA as a downstream molecule of IL-22/IL-17 and IL-4/IL-13,is involved in the occurrence and development of psoriasis and atopic dermatitis.In this paper,the research on the relationship between SCCA and psoriasis and atopic dermatitis is summarized as follows.

关键词

鳞状细胞癌抗原/银屑病/特应性皮炎

Key words

Squamous cell carcinoma antigen/Psoriasis/Atopic dermatitis

引用本文复制引用

出版年

2024
皮肤病与性病
中华医学会昆明分会

皮肤病与性病

影响因子:0.56
ISSN:1002-1310
参考文献量30
段落导航相关论文